This report describes Charcot-Marie-Tooth disease, axonal, type 2O (CMT2O), which is one of several diseases associated with the human cytoplasmic dynein heavy chain gene DYNC1H1 (see MIM:600112). Information about fly models for this and related diseases can be found in the report 'DYNC1H1-related neurodevelopmental and neuromuscular disorders' (FBhh0001596).
[updated Aug. 2024 by FlyBase; FBrf0222196]
Charcot-Marie-Tooth disease (CMT) constitutes a clinically and genetically heterogeneous group of hereditary motor and sensory peripheral neuropathies. CMT is divided into several major types: Type 1 is characterized by demyelination and by a significantly slowed motor median nerve conduction velocity (NCV). Type 2 is characterized by axonal abnormalities and a normal or slightly reduced NCV. "Intermediate" types describe CMT families with nerve conduction velocities, in different affected individuals, that overlap the division between Type 1 and Type 2. Additional types are defined on the basis inheritance patterns. [from MIM:609260 and MIM:606482; 2015.12.15]
Symptoms typically include progressive distal muscle weakness and atrophy, often associated with mild to moderate sensory loss, depressed tendon reflexes, and high-arched feet. [from Gene Reviews, http://www.ncbi.nlm.nih.gov/books/NBK1358 2015.12.15]
[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O](https://omim.org/entry/614228)
[DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1; DYNC1H1](https://omim.org/entry/600112)
Charcot-Marie-Tooth disease type 2O (CMT2O) is caused by heterozygous mutation in the DYNC1H1 gene. [from MIM:614228; 2024.08.27]